ArticleWorld journal of clinical cases2021

Clinical benefit of COX-2 inhibitors in the adjuvant chemotherapy of advanced non-small cell lung cancer: A systematic review and meta-analysis.

Yu-Qiong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.